Clinical Trials Directory

Trials / Unknown

UnknownNCT02220400

Ketamine Prevent POCD

Low Dose Ketamine Prevent the Postoperative Cognitive Dysfunction in Aged Patients Underwent Orthopaedic Surgery,a Randomized Control Double Blinded Multicenter Clinical Trail

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
484 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Previous study demonstrated that neuroinflammation induced by surgery is the main cause of the postoperative cognitive dysfunction. As an agonist of NMDA receptor, ketamine is proved to be an anti-inflammation agent. In present study investigators hypothesized that low dose ketamine would prevent the cognition decline after orthopedic surgery in aged patients.

Conditions

Interventions

TypeNameDescription
DRUGKetamine

Timeline

Start date
2014-09-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2014-08-19
Last updated
2014-08-19

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02220400. Inclusion in this directory is not an endorsement.